Meeting of the Horizontal Working Party on Drugs, Brussels

Europagebouw in Brussel
© Kevin Bergenhenegouwen
date January 15, 2018 10:00
city Brussels, Belgium
location Europa Building i Show location
room Room EB S5
organisation Horizontal Working Party on Drugs (HDG)

H

Council of the European Union

 

1 General Secretariat

 

Brussels, 12 January 2018

 

CM 5576/1/17

 

REV 1

 

JAI

 

CORDROGUE

 

SAN

 

COMMUNICATION

NOTICE OF MEETING AND PROVISIONAL AGENDA

Contact:

hdg@consilium.europa.eu

Tel./Fax:

+32.2.281.3290

Subject:

Meeting of the Horizontal Working Party on Drugs

Date:

15 and 16 January 2018

Time:

10.00, 10.00

Venue:

COUNCIL

 

EUROPA BUILDING

 

Rue de la Loi 155, 1048 BRUSSELS

  • 1. 
    Adoption of the agenda
  • 2. 
    Preparation for the 61st CND session
  • international scheduling of new psychoactive substances:

o presentation by WHO on the work of the Expert Committee on Drug Dependence and on

the substances reviewed by the 39th meeting of the Committee; o discussion on the Proposal for a Council Decision as regards international substance

scheduling.

doc. 5260/17 +ADD 1

CM 5576/1/17 REV 1

1

EN

  • discussion on the draft CND resolutions tabled by the Member States doc. WK 13837/2017 REV 1
  • information on the EU side event to be held at the 61st CND session
  • update on the other side events to be held at the 61st CND session
  • 3. 
    Discussion on implementation of the EU common position on the process towards 2019 global drug policy review
  • presentation by the Civil Society Forum on Drugs doc. WK 175/2018
  • discussion on future EU actions doc. WK 15035/2017
  • preparation for the Expert Consultation on the Improvement on Annual Report Questionnaire (29-31 January 2018, Vienna)
  • 4. 
    Alternatives to coercive sanctions
  • doc. WK 13479/2017 REV 1
  • 5. 
    Proposal for a Council decision on subjecting AB-CHMINACA, ADB-CHMINACA, 5F-MDMB-PINACA, CUMYL-4CN-BINACA, 4-fluoroisobutyrylfentanyl, tetrahydrofuranylfentanyl, and carfentanil to control measures
  • Presentation by the EMCDDA and Europol on risk assessment report

doc. 14685/17, 14704/17, 14723/17, 14728/17, 14729/17, 14730/17, 14738/17

  • Presentation by the Commission

doc. doc. 15871/17, 15872/17, 15873/17, 15875/17, 15877/17, 15878, 15887/17

  • Discussion
  • 6. 
    Information by the Commission on the forthcoming EMCDDA evaluation
  • 7. 
    Drugs and the darknet: perspectives for enforcement, research and policy - presentation by EMCDDA/Europol

CM 5576/1/17 REV 1

2

EN

  • 8. 
    Conference on Drugs in Europe: a bold law enforcement response (December 6-7, 2017)
  • - 
    presentation by Europol and follow-up
  • 9. 
    Preparation for the EU-CELAC Technical Committee meeting (18 April 2017) and XX High Level Meeting of the EU-CELAC Coordination and Cooperation Mechanism on Drugs (21-22 June 2018, Sofia)

doc. WK 15037/2017

  • 10. 
    Preparation for the EU-US dialogue on drugs ( 9 February 2018, Brussels)

doc. 15618/1/17 REV 1

  • 11. 
    Preparation for the EU-Brazil dialogue on drugs (March 2018, Vienna)

doc. 15945/17

  • 12. 
    Preparation for the EU-Western Balkans dialogue on drugs ( 18 April 2018, Brussels)

doc. 5242/18

  • 13. 
    Report on the EU-Eastern partnership dialogue on drugs (29 November 2017)

doc. 15290/17

  • 14. 
    Report on the HDG-Civil Society Forum on Drugs meetings (29 November 2017)
  • 15. 
    Information on relevant international events
  • 16. 
    A.O.B:
  • OSCE action on drugs

NB: Council documents are available on Delegates Portal. Room attendants will provide copies on request at the earliest opportunity.

CM 5576/1/17 REV 1

3

EN


1.

Relevant EU dossiers

2.

More about...